Filing Flows › NRC Health (NRC) › Stock forecast & fair value
NRC Health (NRC) stock forecast and price target
NRC Health (NRC) trades at $25.86. One analyst's price target is $27.00 (+4%).
NRC Health's latest quarter
NRC Health, Q3 2026: revenue $38.4M (+11% year over year), operating margin 23.2%, net earnings $4.7M, operating cash flow $8.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NRC stock?
One analyst's 12-month target is $27.00, +4% from $25.86. The average rating is buy.
Does NRC Health usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is NRC stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.